Jan 30 (Reuters) - Cigna Group CI.N:
Q4 ADJUSTED REVENUE $65.68 BILLION VERSUS IBES ESTIMATE $63.36 BILLION
Q4 ADJUSTED EPS $6.64 VERSUS IBES ESTIMATE $7.82
Q4 MEDICAL CARE RATIO 87.9% VERSUS IBES ESTIMATE 84.84%
OUTLOOK FY ADJUSTED EPS AT LEAST $29.50 VERSUS IBES ESTIMATE $31.50
OUTLOOK FY ADJUSTED REVENUE AT LEAST $252 BILLION VERSUS IBES ESTIMATE $251.95 BILLION
HIGHER MEDICAL COSTS IN STOP LOSS PRODUCT IMPACTED Q4; TAKING ACTIONS TO ADDRESS NEAR-TERM PRESSURES
RAISES QTRLY DIVIDEND 8% TO $1.51/SHARE, APPROVED INCREASE OF $6 BILLION IN SHARE BUYBACKS
Source text: [ID:]
Further company coverage: CI.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.